Roger Sawhney - 21 May 2026 Form 4 Insider Report for ACTUATE THERAPEUTICS, INC. (ACTU)

Reporting relationship
Director
Issuer ticker
ACTU
Reported as of
21 May 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 May 2026, 16:10:59 UTC
Prior SEC filing
15 Jul 2026
Next SEC filing
10 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Paul Lytle, Attorney-in-Fact

Key filing fact

Roger Sawhney filed Form 4 for ACTUATE THERAPEUTICS, INC. (ACTU) on 22 May 2026.

Key facts

  • This page summarizes Roger Sawhney's Form 4 filing for ACTUATE THERAPEUTICS, INC. (ACTU).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 22 May 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 15 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001858748 Primary reporting owner

Sawhney Roger

Relationship
Director
Address
C/O ACTUATE THERAPEUTICS, INC., 1751 RIVER RUN, SUITE 400, FORT WORTH
Signature
/s/ Paul Lytle, Attorney-in-Fact
Signature date
22 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACTU transaction Derivative

Stock Options

Award

Transaction value
Shares
+15,000
Change %
Price
$0.000000*
Shares after
15,000
Date
21 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,000
Exercise price
$2.42
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options will vest in full on the anniversary of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .